These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12975255)

  • 1. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
    Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
    Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
    Yang A; Pizzulli L; Lüderitz B
    Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
    Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
    Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased endogenous endothelin-1 in coronary circulation is associated with restenosis after coronary angioplasty.
    Takase H; Sugiyama M; Nakazawa A; Toriyama T; Hayashi K; Goto T; Sato K; Ikeda K; Ueda R; Dohi Y
    Can J Cardiol; 2003 Jul; 19(8):902-6. PubMed ID: 12876610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) trial.
    Tamai H; Berger PB; Tsuchikane E; Suzuki T; Nishikawa H; Aizawa T; Fujii K; Nozaki Y; Kyo E; Kobayashi T; Reiber J; Van Weert AW;
    Am Heart J; 2004 Mar; 147(3):E9. PubMed ID: 14999211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
    Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
    Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J; Hudzik B; Romanowski W; Wilczek K; Danikiewicz A; Gasior M; Polonski L; Zubelewicz-Szkodzinska B
    J Biol Regul Homeost Agents; 2010; 24(2):149-56. PubMed ID: 20487628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
    Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
    Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris.
    Tanaka T; Matsushita M; Oka Y; Sada T; Kira Y
    J Cardiol; 2001 Dec; 38(6):311-7. PubMed ID: 11806088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin expression in coronary circulation after stent implantation as a prognostic factor for restenosis.
    Hojo Y; Ikeda U; Mizuno O; Katsuki TA; Shimada K
    Int J Cardiovasc Intervent; 2003; 5(4):190-4. PubMed ID: 14630561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a pressure gradient distal to implanted bare-metal stent on in-stent restenosis after percutaneous coronary intervention.
    Jensen LO; Thayssen P; Thuesen L; Hansen HS; Lassen JF; Kelbaek H; Junker A; Hansen KN; Boetker HE; Krusell LR; Pedersen KE
    Circulation; 2007 Dec; 116(24):2802-8. PubMed ID: 18025527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis.
    Ge J; Shen C; Liang C; Chen L; Qian J; Chen H
    Int J Cardiol; 2006 Sep; 112(1):85-90. PubMed ID: 16316696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis.
    Mukherjee M; De Benedictis C; Jewitt D; Kakkar VV
    Thromb Haemost; 1996 Feb; 75(2):258-60. PubMed ID: 8815572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.
    Takamori N; Azuma H; Kato M; Hashizume S; Aihara K; Akaike M; Tamura K; Matsumoto T
    Circulation; 2004 Feb; 109(4):481-6. PubMed ID: 14744972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.